Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,978 Psoriasis
clinical trials

Psoriasis Clinical Trial
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy
Status: Enrolling, Phase III
Updated: 12/31/1969
International Dermatology Research, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Psoriasis Clinical Trial
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Psoriasis Clinical Trial
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy
Status: Enrolling, Phase III
Updated: 12/31/1969
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
Status: Enrolling, Phase
Updated: 12/31/1969
Greenwich Village Dermatology
mi
from
New York, NY
Click here to add this to my saved trials
Palmoplantar Pustulosis Clinical Trial
A Study to Evaluate the Efficacy and Safety of ANB019 in Subjects With Palmoplantar Pustulosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Investigative Site 057
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Psoriasis Clinical Trial
FibroScan ® Study: Assessing Liver Fibrosis in Patients Using Methotrexate for Psoriasis
Status: Enrolling
Updated: 12/31/1969
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Meridian Clinical Research, LLC
mi
from
Savannah, GA
Click here to add this to my saved trials
Psoriasis Clinical Trial
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Psoriasis Treatment Center of Central New Jersey
mi
from
East Windsor, NJ
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Center for Clinical Studies
mi
from
Houston, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Oregon Dermatology & Research Center
mi
from
Portland, OR
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Steroid-reducing Effects of Crisaborole
Status: Enrolling, Phase IV
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study to Evaluate the Impact of Apremilast (CC-10004) on MRI Outcomes in Subjects With Psoriatic Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study to Evaluate the Impact of Apremilast (CC-10004) on MRI Outcomes in Subjects With Psoriatic Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Arthritis and Rheumatology of Georgia
mi
from
Atlanta, GA
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study to Evaluate the Impact of Apremilast (CC-10004) on MRI Outcomes in Subjects With Psoriatic Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Malcom Randall VA Medical Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study to Evaluate the Impact of Apremilast (CC-10004) on MRI Outcomes in Subjects With Psoriatic Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Integral Rheumatology & Immunology Specialists
mi
from
Plantation, FL
Click here to add this to my saved trials
Psoriasis Clinical Trial
Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Psoriasis Clinical Trial
Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Driscoll Children's Hospital
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Psoriasis Clinical Trial
Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Dawes Fretzin Dermatology Group
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Psoriasis Clinical Trial
Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Wearable Skin Sensors to Assess Nocturnal Scratch Behavior
Status: Upcoming, Phase
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is
Status: Upcoming, Phase II
Updated: 12/31/1969
Menter Dermatology Research Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is
Status: Upcoming, Phase II
Updated: 12/31/1969
Clinical Partners, LLC
mi
from
Johnston, RI
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Psoriasis Clinical Trial
Status: Upcoming
Accord Clinical Research
mi
from
Port Orange, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Hydration Sensor for Atopic Dermatitis
Status: Upcoming, Phase
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is
Status: Upcoming, Phase II
Updated: 12/31/1969
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tradipitant in Treatment-Resistant Pruritus Associated With Atopic Dermatitis
Status: Upcoming, Phase II
Updated: 2/2/2016
Sadick Research Group
mi
from
New York, NY
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis
Status: Upcoming, Phase II
Updated: 12/31/1969
Center for Clinical Studies
mi
from
Houston, TX
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis
Status: Upcoming, Phase II
Updated: 12/31/1969
Center for Clinical Studies
mi
from
Webster, TX
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is
Status: Upcoming, Phase II
Updated: 12/31/1969
Total Skin and Beauty Dermatology Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is
Status: Upcoming, Phase II
Updated: 12/31/1969
Dermatology Research Associates
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is
Status: Upcoming, Phase II
Updated: 12/31/1969
Southern California Dermatology, Inc.
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study to Test Safety and Tolerability of a Study Drug Called MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Patients With Moderate to Severe Atopic Dermatitis
Status: Upcoming, Phase II
Updated: 12/31/1969
Progressive Clinical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis
Status: Upcoming, Phase II
Updated: 12/31/1969
Stanford Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is
Status: Upcoming, Phase II
Updated: 12/31/1969
Psoriasis Treatment Center of Central New Jersey
mi
from
East Windsor, NJ
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is
Status: Upcoming, Phase II
Updated: 12/31/1969
Dawes Fretzin Clinical Research Group, LLC
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is
Status: Upcoming, Phase II
Updated: 12/31/1969
Health Concepts
mi
from
Rapid City, SD
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Psoriasis Clinical Trial
Status: Upcoming
Achieve Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
ASIS for Enbrel in Plaque Psoriasis
Status: Upcoming, Phase I, II
Updated: 6/22/2015
Automatic Subdermal Injector System, Inc
mi
from
Westminster, CA
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is
Status: Upcoming, Phase II
Updated: 12/31/1969
Center for Clinical Studies
mi
from
Houston, TX
Click here to add this to my saved trials
Psoriasis Clinical Trial
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is
Status: Upcoming, Phase II
Updated: 12/31/1969
Center for Clinical Studies
mi
from
Webster, TX
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Rheumatology Clinical Trial
Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Status: Enrolling, Phase
Updated: 12/31/1969
Belleville Dermatology Ctr, PA
mi
from
Belleville, NJ
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Rheumatology Clinical Trial
Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Status: Enrolling, Phase
Updated: 12/31/1969
Hudson Dermatology and Skin Cancer Center
mi
from
Hoboken, NJ
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Rheumatology Clinical Trial
Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Status: Enrolling, Phase
Updated: 12/31/1969
Skagit Valley Medical Center
mi
from
Mount Vernon, WA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Rheumatology Clinical Trial
Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Status: Enrolling, Phase
Updated: 12/31/1969
Dermatology Associates Of Plymouth Meeting
mi
from
Plymouth Meeting, PA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Rheumatology Clinical Trial
Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Status: Enrolling, Phase
Updated: 12/31/1969
Buffalo Medical Group, PC
mi
from
Williamsville, NY
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Hazleton, PA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Kingsport, TN
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Ormond Bech, FL
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
mi
from
North Hollywood, CA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling, Phase III
Updated: 4/24/2014
Clinical Research Facility
mi
from
Webster, TX
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Other Clinical Trial
Pilot Tape Harvesting Study
Status: Enrolling
Updated: 3/25/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Encino, CA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Irvine, CA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Status: Enrolling, Phase III
Updated: 7/6/2016
Glenmark Investigational Site 52
mi
from
Macon, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Corning, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Edina, MN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Inglewood, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Jenkintown, PA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Lomita, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Normal, IL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Norman, OK
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Overland Park, KS
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Plymouth, MN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Portsmouth, NH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Psoriasis Clinical Trial
This Study is Being Conducted to Evaluate the Safety, Tolerability, and Efficacy of KD025 Administered Orally for 16 Weeks to Subjects With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy or Phototherapy.
Status: Enrolling, Phase II
Updated: 3/6/2017
Dermatology Specialists Research
mi
from
New Albany, IN
Click here to add this to my saved trials
Dermatology / Plastic Surgery Clinical Trial
Maintaining Lower Levels of Care Through Automated Perineal Hygiene
Status: Enrolling
Updated: 12/31/1969
The Canterbury
mi
from
Rancho Palos Verdes, CA
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
American Health Research /ID# 164354
mi
from
Charlotte, NC
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Luke's Hospital /ID# 165671
mi
from
Duluth, MN
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Jude Heritage /ID# 159980
mi
from
Fullerton, CA
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
SW Rheumatology Res. LLC /ID# 159993
mi
from
Mesquite, TX
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
NYU Langone Medical Center /ID# 163230
mi
from
New York, NY
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Four Rivers Clinical Research, Inc. /ID# 159982
mi
from
Paducah, KY
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Arthritis Center, Inc. /ID# 163465
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Clayton Medical Associates, PC /ID# 159878
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Arthritis Northwest, PLLC /ID# 166380
mi
from
Spokane, WA
Click here to add this to my saved trials
1 … 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20